(Q54228289)

26 May 2018

title

Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity (English)

1 reference

26 August 2024

1 reference

D. Raspadori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7694662

26 August 2024

F. Lauria

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7694662

26 August 2024

M. A. Ventura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7694662

26 August 2024

D. Rondelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7694662

26 August 2024

S. Tura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7694662

26 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7694662

26 August 2024

publication date

1 November 1993

1 reference

26 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01715049.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01715049/fulltext.html

26 August 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF01715049

26 August 2024

1 reference

26 August 2024

1 reference

26 May 2018

volume

67

1 reference

26 May 2018

issue

5

1 reference

26 May 2018

page(s)

213-216

1 reference

26 May 2018

Human natural killer cells: biologic and pathologic aspects

cites work

1 reference

12 December 2020

Induction of NK cell activity against fresh human leukemia in culture with interleukin 2

1 reference

12 December 2020

Mechanism of cytotoxicity by natural killer (NK) cells

1 reference

12 December 2020

Adhesion characteristics of human interleukin 2-activated natural killer cells

1 reference

12 December 2020

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease

1 reference

12 December 2020

Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties

1 reference

12 December 2020

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

1 reference

12 December 2020

Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.

1 reference

12 December 2020

Interleukin 2 and the Treatment of Leukemia and Lymphoma

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

12 December 2020

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study

1 reference

12 December 2020

In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival

1 reference

12 December 2020

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

1 reference

12 December 2020

Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.

1 reference

12 December 2020

A supportive role of neural cell adhesion molecule (NCAM) in adhesion between leukaemic blasts and cytotoxic lymphocytes

1 reference

12 December 2020

CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing.

1 reference

12 December 2020

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01715049

1 reference

26 May 2018

release_kx5jxf7gx5aeneeocojy44zd5y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kx5jxf7gx5aeneeocojy44zd5y

24 November 2022

mapped directly with Wikidata item

1 reference

26 May 2018